Related Experiment Video
Updated: Dec 21, 2025
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.0K
MCV Truncated Large T antigen interacts with BRD4 in tumors
Reety Arora1, Arushi Vats1,2, Vrushali Chimankar1,3
1Sudhir Krishna Group, National Centre for Biological Sciences, TIFR, Bangalore, India.
Matters
|May 13, 2020
Summary
Merkel Cell Polyomavirus (MCV) tumor antigen interacts with the BRD4 protein, but does not enhance viral transcription. This finding is crucial for developing targeted therapies for MCV-associated cancers.
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Merkel Cell Polyomavirus (MCV) is a causative agent of Merkel Cell Carcinoma.
- MCV oncogenic transformation involves viral genome integration and expression of T antigens.
- BRD4 protein regulates viral oncoprotein expression in virus-associated cancers.
Purpose of the Study:
- To investigate the interaction between MCV truncated tumor large T antigen (LT) and BRD4.
- To determine if BRD4 regulates the transcriptional activity of the MCV Non Coding Control Region (NCCR).
Main Methods:
- Co-immunoprecipitation to assess protein interactions.
- Immunofluorescence to confirm nuclear co-localization.
- Reporter assays to measure transcriptional activity of the MCV NCCR.
Main Results:
- MCV truncated tumor LT antigen interacts with BRD4 protein.
- MCV tumor LT and BRD4 protein complex co-localizes within the nucleus.
- BRD4, full-length LT, and small T antigen enhanced NCCR transcriptional activity, but truncated tumor LT did not.
Conclusions:
- The interaction between MCV truncated tumor LT and BRD4 is confirmed.
- BRD4 does not enhance the transcriptional activity of the MCV NCCR via truncated tumor LT.
- These findings contribute to understanding MCV tumorigenesis and identifying new therapeutic targets.
